The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Integrating lifestyle care into low back pain management resulted in greater improvements in disability, weight loss and ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
The following is a summary of “Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of ...
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey ...